Acute Hyponatraemia Protocol
A correction rate that will not cause osmotic demyelination, gated by severity · v1.1This selection applies only if active IV correction is clinically indicated. The engine will gate this decision.
ODS (formerly "central pontine myelinolysis") occurs when chronic hyponatraemia is corrected too rapidly. In chronic hyponatraemia, brain cells adapt by losing organic osmolytes. If extracellular Na rises too fast, water is pulled out of adapted neurons, causing demyelination. Symptoms appear 2 to 6 days after overcorrection: dysarthria, dysphagia, quadriparesis, "locked-in syndrome," and potentially death. ODS is irreversible. Prevention is the only strategy.
An empirical drip of 3% Hypertonic Saline, started without the Total Body Water calculated and the volume status defined, is one of the commoner routes to ODS. 3% saline is a drug, not a fluid. Continuous infusions belong in an ICU or HDU, with ABG or VBG electrolytes every 2 to 4 hours.
Not every patient with Na⁺ < 135 needs IV correction. This tool gates its output based on severity and clinical context:
| Na⁺ Range | Severity | Default Management |
|---|---|---|
| 130 to 134 | Mild | No IV correction. Fluid restriction (eu/hyper) or NS volume resuscitation (hypo). Investigate cause. |
| 125 to 129 | Moderate | Fluid restriction primary (eu/hyper). Active IV correction only if severely symptomatic or trending down. |
| 120 to 124 | Severe | Active correction indicated. ICU/HDU admission. Calculated infusion. |
| 110 to 119 | Profound | Urgent active correction. ICU mandatory. Consider DDAVP clamping. |
| < 110 | Critical | Life-threatening emergency. ICU, bolus protocol if symptomatic, strict monitoring. |
| Chronicity | ODS Risk | Correction Approach |
|---|---|---|
| Acute (<48h) | Very Low | More aggressive correction permitted (up to 10 mEq/L/24h). Brain has not adapted. |
| Chronic (>48h) | HIGH | Strict slow correction (8 mEq/L/24h max, 6 for high-risk). Brain has adapted by expelling osmolytes. |
| Unknown Duration | Treat as Chronic | If you cannot prove onset was <48h with prior normal labs, assume chronic. |
| Scenario | Max 24h Rise | Notes |
|---|---|---|
| Standard Risk, Chronic/Unknown | 8 mEq/L | European (2014) and API (2019) consensus |
| High Risk (SHAM), Chronic/Unknown | 6 mEq/L | Sterns 2015 |
| Documented Acute, Standard Risk | 10 mEq/L | ODS risk very low |
| Documented Acute, High Risk | 8 mEq/L | Still apply caution despite acuity |
| Volume Status | Clinical Script & Cautions | Primary Action |
|---|---|---|
| Hypovolaemic | Dry mucosa, flat JVP, tachycardia. Caution: Once volume is restored with NS, ADH switches off, the kidneys dump free water, and the Na⁺ runs past the safe limit before anyone has re-checked it. | NS to restore volume. Monitor closely for auto-correction. Consider prophylactic DDAVP clamping. |
| Euvolaemic | Normal exam. Think SIADH, hypothyroidism, adrenal insufficiency. Caution: NS can paradoxically worsen SIADH. Always check TSH and morning cortisol first. | Fluid restriction (800-1000 mL/day). HTS only if severely symptomatic. |
| Hypervolaemic | Oedema, raised JVP, ascites. Total body Na⁺ is high but water is massively higher. | Fluid restriction + Loop Diuretics. NEVER give continuous saline. |
Patients at highest risk for ODS require the strict 6 mEq/L/24hr limit. Remember SHAM:
- S - Severe baseline hyponatraemia (< 105 mEq/L)
- H - Hypokalaemia (concurrent)
- A - Alcoholism / Advanced Liver Disease
- M - Malnutrition (severe)
3% NaCl contains 513 mEq/L of Na. It is used for symptomatic hyponatraemia (seizures, coma) to rapidly raise Na by 1 to 2 mEq/L per hour for the first 2 to 3 hours.
Fixed bolus (preferred for emergencies): 150 mL of 3% NaCl IV over 20 minutes. Recheck Na after 20 minutes. Repeat up to 2 more times if symptoms persist (maximum 3 boluses). Each 150 mL bolus raises Na by approximately 1.5 to 2 mEq/L in a 70 kg patient.
Correcting hypokalaemia simultaneously raises serum Na⁺. K⁺ enters cells and displaces Na⁺ outward. Every 1 mEq of K⁺ replaced has the same osmotic effect as 1 mEq of Na⁺ infused. K⁺ correction must be counted against the 24h Na⁺ correction limit.
2. The Normal Saline Caution in SIADHIn SIADH, kidneys maximally concentrate urine. If you infuse 1 litre of 0.9% NS (154 mEq Na⁺ in 1000 mL), the kidneys may excrete those 154 mEq in only 500 mL of concentrated urine, retaining 500 mL of electrolyte-free water. Net effect: you have worsened the hyponatraemia despite giving sodium.
3. Proactive DDAVP Clamping StrategyProactive DDAVP clamping is DDAVP at the start, not in reserve for a rescue. Give DDAVP 1 to 2 mcg IV at the start of therapy, then administer HTS at a calculated rate. The patient becomes a closed system. That is the assumption the Adrogue-Madias formula was built on, and the only state in which its prediction holds. The evidence for the proactive approach is observational rather than randomised. It matters most in the hypovolaemic patient, who is at the highest risk of auto-correction overshoot once the volume is restored.
4. Pseudohyponatraemia & Dilutional HyponatraemiaHypertonic hyponatraemia: Hyperglycaemia pulls water out of cells, diluting sodium. For every 100 mg/dL rise in glucose above 100, Na drops by 1.6 mEq/L. Corrected Na = Measured Na + 1.6 × ((Glucose - 100) / 100). If corrected Na is normal, treat the hyperglycaemia, not the sodium.
Isotonic hyponatraemia: Severe hyperlipidaemia or hyperproteinaemia (myeloma). Serum osmolality will be normal. Not true hyponatraemia.
Diagnostic criteria: (1) Serum Na < 135, (2) Serum osmolality < 275, (3) Urine osmolality > 100, (4) Urine Na > 40, (5) Euvolaemic, (6) Normal thyroid and adrenal function. Common causes in India: CNS infections (TB meningitis, encephalitis), lung disease (TB, pneumonia, lung cancer), drugs (SSRIs, Carbamazepine, Cyclophosphamide).
Management: (1) Fluid restriction (800 to 1000 mL/day). (2) Salt tablets (NaCl 3g TDS with meals). (3) Tolvaptan 15 mg PO daily if fluid restriction fails (Indian brands: Tolva, Natrise). Start in hospital with Na monitoring every 6 hours. (4) Treat the underlying cause.
ΔNa⁺ = (Infusate Na⁺ - Serum Na⁺) / (Total Body Water + 1)
Limitation: Assumes zero renal water handling. Systematically underestimates correction in hypovolaemic patients and may overestimate in SIADH.
| IV Fluid | Na⁺ (mEq/L) | Typical Use |
|---|---|---|
| 3% HTS | 513 | ICU bolus and infusion for symptomatic hyponatraemia |
| 1.6% HTS | 274 | Peripheral line option |
| 0.9% NS | 154 | Volume resuscitation in hypovolaemic hyponatraemia |
| Ringer's Lactate | 130 | Mild hypovolaemia |
- Stop all sodium-containing IV fluids and K⁺ replacement immediately.
- Give D5W at 6 mL/kg IV over 1 to 2 hours.
- Give DDAVP 2 mcg IV every 8 hours.
- Re-check serum Na⁺ every 1 to 2 hours until stabilised.
- Goal: Re-lower Na⁺ back to within the originally intended limit. Re-lower without hesitating. The risk from overcorrection is far greater than the risk of putting the sodium transiently back down.
It is written for adults, and its age field starts at 18. It classifies the sodium, sets a ceiling and calculates an infusion, and it does not establish the cause: the SIADH, the cirrhosis, the hypothyroidism or the thiazide that produced the number is left entirely to you. It does not manage exercise-associated hyponatraemia, beer potomania or psychogenic polydipsia as distinct entities. It does not decide who needs tolvaptan, or for how long. It does not cover hyponatraemia in pregnancy or in children. And it cannot watch the patient: every number it prints assumes the monitoring schedule is actually followed, and the commonest way this goes wrong is not a miscalculation but a sodium nobody re-checked at hour four.
Algorithm References & Evidence Base
- Verma A, et al. API Expert Consensus on Management of Hyponatraemia. JAPI. 2019.
- Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342(21):1581-1589.
- Spasovski G, et al. Clinical practice guideline on hyponatraemia. Eur J Endocrinol. 2014;170(3):G1-47.
- Sterns RH. Disorders of Plasma Sodium. N Engl J Med. 2015;372(1):55-65.
- Perianayagam A, et al. DDAVP for overcorrection prevention. CJASN. 2008;3(2):331-336.
- Sterns RH, et al. ODS following correction of hyponatremia. N Engl J Med. 1986;314(24):1535-1542.
- Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1-S42.
How to Cite This Tool
AMA Style:
Umakanth S. Acute Hyponatraemia Protocol. MEDiscuss. Published 2026. Accessed .
Vancouver Style:
Umakanth S. Acute Hyponatraemia Protocol [Internet]. MEDiscuss.org; 2026 [cited ]. Available from:
Save this calculation
Whatever you type here stays on this device and is not sent anywhere. The server receives only a scrambled code made from it, so nobody with access to the server can tell which patient a saved calculation belongs to. Enter the same nickname the next time to see that patient's earlier values. What is stored
Last revised: 29 July 2026
